{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:03:38Z","timestamp":1790874218835,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eimce.2026.503223","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:53:47Z","timestamp":1790870027000},"page":"503223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetic and pharmacodynamic concepts in antibiotic therapy for clinicians"],"prefix":"10.1016","volume":"44","author":[{"given":"Alejandro","family":"D\u00edez-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2026.503223_bib0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.eimce.2026.503223_bib0310","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/molecules28248038","article-title":"The bioavailability of drugs \u2013 the current state of knowledge","volume":"28","author":"Stielow","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.eimce.2026.503223_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkac383","article-title":"Subcutaneously administered antibiotics: a review","volume":"78","author":"Jumpertz","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0320","first-page":"CD008319","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"8","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eimce.2026.503223_bib0325","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(19)30574-2","article-title":"Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial","volume":"20","author":"Niederman","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimce.2026.503223_bib0330","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/17460441.2017.1378176","article-title":"Absorption sites of orally administered drugs in the small intestine","volume":"12","author":"Murakami","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.eimce.2026.503223_bib0335","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s11695-020-04623-z","article-title":"The effect of bariatric surgery on oral antibiotic absorption: a systematic review","volume":"30","author":"Anvari","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.eimce.2026.503223_bib0340","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40262-024-01377-0","article-title":"Together or apart? Revealing the impact of dietary interventions on bioavailability of quinolones: a systematic review with meta-analyses","volume":"63","author":"Wiesner","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.eimce.2026.503223_bib0345","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/jac\/dkae028","article-title":"Do dietary interventions exert clinically important effects on the bioavailability of \u03b2-lactam antibiotics? A systematic review with meta-analyses","volume":"79","author":"Wiesner","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0350","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2026.503223_bib0355","doi-asserted-by":"crossref","first-page":"1521091","DOI":"10.3389\/fcimb.2025.1521091","article-title":"Enhancing antibiotic therapy through comprehensive pharmacokinetic\/pharmacodynamic principles","volume":"15","author":"Alikhani","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.eimce.2026.503223_bib0360","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2010.01.023","article-title":"Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic\/pharmacodynamic indices","volume":"35","author":"Barbour","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2026.503223_bib0365","doi-asserted-by":"crossref","first-page":"e01663","DOI":"10.1128\/AAC.01663-17","article-title":"Seventy-five years of research on protein binding","volume":"62","author":"Dalhoff","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0370","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40262-017-0572-y","article-title":"Intracellular pharmacokinetics of antibacterials and their clinical implications","volume":"57","author":"Pea","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.eimce.2026.503223_bib0375","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40262-013-0062-9","article-title":"Clinical pharmacokinetics of antibacterials in cerebrospinal fluid","volume":"52","author":"Di Paolo","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.eimce.2026.503223_bib0380","doi-asserted-by":"crossref","first-page":"e01998","DOI":"10.1128\/AAC.01998-20","article-title":"A systematic review of studies reporting antibiotic pharmacokinetic data in the cerebrospinal fluid of critically ill patients with uninflamed meninges","volume":"65","author":"Kumta","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0385","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimce.2026.503223_bib0390","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/biom15060864","article-title":"Drug transporters and metabolizing enzymes in antimicrobial drug pharmacokinetics: mechanisms, drug-drug interactions, and clinical implications","volume":"15","author":"Lin","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.eimce.2026.503223_bib0395","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/phar.2672","article-title":"Systematic review of drug\u2013drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management","volume":"42","author":"MacDougall","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimce.2026.503223_bib0400","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.34067\/KID.0003202022","article-title":"Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR","volume":"3","author":"Chen","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.eimce.2026.503223_bib0405","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02534-17","article-title":"\u03b2-Lactam dosage regimens in septic patients with augmented renal clearance","volume":"62","author":"Jacobs","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0410","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2215\/CJN.08140718","article-title":"Clinical pharmacology of antibiotics","volume":"14","author":"Eyler","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.eimce.2026.503223_bib0415","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1021\/acsinfecdis.5c00424","article-title":"Identifying modulators of the post-antibiotic effect","volume":"11","author":"Gilberti","year":"2025","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.eimce.2026.503223_bib0420","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eimce.2026.503223_bib0425","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40265-023-01893-6","article-title":"Extended and continuous infusion of novel protected \u03b2-lactam antibiotics: a narrative review","volume":"83","author":"Venuti","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.eimce.2026.503223_bib0430","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2165\/11597020-000000000-00000","article-title":"Pharmacological considerations for the proper clinical use of aminoglycosides","volume":"71","author":"Pagkalis","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.eimce.2026.503223_bib0435","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2174\/1566524023666230801160452","article-title":"Aminoglycosides: single- or multiple-daily dosing? An updated qualitative systematic review of randomized trials on toxicity and efficacy","volume":"24","author":"Karimzadeh","year":"2024","journal-title":"Curr Mol Med"},{"issue":"suppl 2","key":"10.1016\/j.eimce.2026.503223_bib0440","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/428053","article-title":"Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"41","author":"Wispelwey","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2026.503223_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114171","article-title":"Pharmacokinetics and pharmacodynamics of peptide antibiotics","volume":"183","author":"Bian","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.eimce.2026.503223_bib0450","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/AAC.03147-14","article-title":"Optimizing the clinical use of vancomycin","volume":"60","author":"\u00c1lvarez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1016\/j.eimce.2026.503223_bib0455","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0924-8579(01)00406-X","article-title":"Macrolides: pharmacokinetics and pharmacodynamics","volume":"18","author":"Van Bambeke","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2026.503223_bib0460","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/phar.2376","volume":"40","author":"Rybak","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimce.2026.503223_bib0465","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"14","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.eimce.2026.503223_bib0470","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Cant\u00f3n","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.eimce.2026.503223_bib0475","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01373-22","article-title":"Mutant prevention concentration, frequency of spontaneous mutant selection, and mutant selection window \u2013 a new approach to the in vitro determination of the antimicrobial potency of compounds","volume":"67","author":"Krajewska","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0480","doi-asserted-by":"crossref","first-page":"127221","DOI":"10.1016\/j.micres.2022.127221","article-title":"Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: an updated review","volume":"266","author":"Li","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.eimce.2026.503223_bib0485","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/pathogens13110975","article-title":"Multidrug resistant Pseudomonas aeruginosa in clinical settings: a review of resistance mechanisms and treatment strategies","volume":"13","author":"Schwartz","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.eimce.2026.503223_bib0490","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2174\/1381612043383377","article-title":"Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors","volume":"10","author":"Tateda","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.eimce.2026.503223_bib0495","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1378\/chest.125.2_suppl.62S","article-title":"Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa","volume":"125","author":"Wozniak","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.eimce.2026.503223_bib0500","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1038\/s41598-020-65602-z","article-title":"Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli","volume":"10","author":"Ching","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.eimce.2026.503223_bib0505","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/jac\/dkz226","article-title":"Inoculum effect of \u03b2-lactam antibiotics","volume":"74","author":"Lenhard","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0510","doi-asserted-by":"crossref","first-page":"O831","DOI":"10.1111\/1469-0691.12677","article-title":"In vitro and in vivo activities of piperacillin\u2013tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae","volume":"20","author":"Harada","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2026.503223_bib0515","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae069","article-title":"Clinical significance of cefazolin inoculum effect in serious MSSA infections: a systematic review","volume":"6","author":"Lo","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.eimce.2026.503223_bib0520","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1038\/s41598-025-90762-1","article-title":"Antimicrobial activity of cephamycins and \u03b2-lactam\/\u03b2-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula","volume":"15","author":"Wi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.eimce.2026.503223_bib0525","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00468-20","article-title":"The emerging role of \u03b2-lactams in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"64","author":"Molina","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2026.503223_bib0530","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tim.2018.10.007","article-title":"The eagle effect and antibiotic-induced persistence: two sides of the same coin?","volume":"27","author":"Prasetyoputri","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.eimce.2026.503223_bib0535","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","article-title":"Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections \u2013 a systematic review and meta-analysis","volume":"24","author":"Diaz","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 1","key":"10.1016\/j.eimce.2026.503223_bib0540","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2014.10.024","article-title":"ESCMID guideline for the diagnosis and treatment of biofilm infections 2014","volume":"21","author":"H\u00f8iby","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2026.503223_bib0545","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00503-22","article-title":"Treatment of bacterial infections with \u03b2-lactams: cooperation with innate immunity","volume":"91","author":"Mondem\u00e9","year":"2023","journal-title":"Infect Immun"},{"key":"10.1016\/j.eimce.2026.503223_bib0550","series-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 15.0, 2025","year":"2025"},{"key":"10.1016\/j.eimce.2026.503223_bib0555","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimce.2026.503223_bib0560","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/CCM.0000000000004326","article-title":"Continuous versus intermittent infusion of vancomycin and the risk of acute kidney injury in critically ill adults: a systematic review and meta-analysis","volume":"48","author":"Flannery","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimce.2026.503223_bib0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1060028019865873","article-title":"Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update","volume":"54","author":"Hoff","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eimce.2026.503223_bib0570","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eimce.2026.503223_bib0575","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00190-19","article-title":"Intrathecal antibacterial and antifungal therapies","volume":"33","author":"Nau","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimce.2026.503223_bib0580","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijantimicag.2013.09.002","article-title":"Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies","volume":"42","author":"Hu","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2026.503223_bib0585","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/phar.70010","article-title":"A review of antibiotic safety in pregnancy \u2013 2025 update","volume":"45","author":"Nguyen","year":"2025","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimce.2026.503223_bib0590","doi-asserted-by":"crossref","first-page":"967311","DOI":"10.3389\/fpubh.2022.967311","article-title":"Expert consensus statement on therapeutic drug monitoring and individualization of linezolid","volume":"10","author":"Lin","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.eimce.2026.503223_bib0595","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/phar.4602","article-title":"Fixed dose daptomycin: an opportunity for pharmacokinetic\/pharmacodynamic optimization in Staphylococcus aureus infections","volume":"44","author":"Olney","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimce.2026.503223_bib0600","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/phar.2505","article-title":"A guide to therapeutic drug monitoring of \u03b2-lactam antibiotics","volume":"41","author":"Fratoni","year":"2021","journal-title":"Pharmacotherapy"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:20:01Z","timestamp":1790871601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X26001590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2529993X26001590"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503223","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and pharmacodynamic concepts in antibiotic therapy for clinicians","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"503223"}}